Pure Extracts’ and Golden Harvests’ Joint Venture Receives Medical Prequalification Status Letter in Michigan
Pure Extracts Technologies Corp. (OTC: PRXTF) and Grown Rogue International Inc. have partnered in a joint venture, Pure Grown Extracts, which has secured its medical Prequalification Status from the Michigan Marijuana Regulatory Agency. This approval allows them to apply for a facility license as they prepare to establish operations in Michigan, a key market for cannabis. With Michigan cannabis sales increasing over 50% year-over-year, the joint venture aims to scale rapidly, leveraging Pure Extracts’ expertise and product portfolio.
- Received medical Prequalification Status Letter from Michigan Marijuana Regulatory Agency.
- Joint venture aims to meet rising demand in Michigan's expanding cannabis market.
- Monthly cannabis sales in Michigan increased over 50% from last year.
- Cannabis remains federally illegal in the U.S., posing regulatory risks.
- Potential for stricter enforcement of federal cannabis laws could impact operations.
VANCOUVER, British Columbia and MEDFORD, Ore., Dec. 15, 2021 (GLOBE NEWSWIRE) -- Pure Extracts Technologies Corp. (“Pure Extracts”) (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) and Grown Rogue International Inc.’s (“Grown Rogue”) (CSE: GRIN) (OTC: GRUSF) partner, Golden Harvests, LLC, are pleased to announce that their Michigan extraction joint venture (JV) company, Pure Grown Extracts, LLC (“Pure Grown Extracts”), received its medical Prequalification Status Letter from the Michigan Marijuana Regulatory Agency (MRA) on November 23, 2021.
This letter was issued pursuant to the licensing provisions of the Medical Marihuana Facilities Licensing Act (MMFLA) and associated rules and allows Pure Grown Extracts to submit a facility license application 60 days prior to when the facility will be ready for inspection by the MRA.
“We are excited to be ramping this project up with Golden Harvests in Michigan, where cannabis sales continue to set records with monthly sales up over
The goal of the JV is to bring Pure Extracts’ portfolio of products to Michigan and to expand Grown Rogue’s product offering. Pure Extracts is a plant-based extraction company focused on cannabis and hemp based out of British Columbia, Canada and will provide a mix of equipment, cash, and extraction expertise to the venture, which will allow the partners to rapidly scale-up to meet the rising demand for processed products throughout the state. Grown Rogue is a multi-state operating (MSO) cannabis company with operations and assets in Oregon and in Michigan where they are already doing business with over 100 dispensaries throughout the state.
"We are pleased to have received such a timely response from the MRA on our medical cannabis processing application and look forward to finishing the construction and getting additional award-winning products into the Michigan market to supplement our leading flower brand already established in the state,” said Obie Strickler, CEO of Grown Rogue.
The joint venture plans to build-out existing space in the 80,000 sq. ft. facility in Bay City where it has the ability to produce Pure Extracts’ branded concentrates, cartridges, edibles and tinctures as well as a suite of Grown Rogue products capturing the west coast innovation they are known for.
About Grown Rogue
Grown Rogue International (CSE: GRIN | OTC: GRUSF) is a vertically integrated, multi-state Cannabis family of brands on a mission to inspire consumers to “enhance experiences” through cannabis. We have combined an expert management team, award winning grow team, state of the art indoor and outdoor manufacturing facilities, and consumer insight-based product categorization, to create innovative products thoughtfully curated from “seed to experience.” The Grown Rogue family of products include sungrown and indoor premium flower, along with nitro sealed indoor and sungrown pre-rolls and jars.
About Pure Extracts
Pure Extracts Technology Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) features an all-new, state-of-the-art processing facility located just 20 minutes north of world-famous Whistler, British Columbia. The bespoke facility has been constructed to European Union GMP standards aiming towards export sales of products and formulations, including those currently restricted in Canada, into European jurisdictions where they are legally available. Health Canada, under the Cannabis Act, granted Pure Extracts its Standard Processing License on September 25, 2020, and its Sales Amendment on July 19, 2021. The company’s stock began trading on the Canadian Securities Exchange (CSE) on November 5, 2020.
FORWARD-LOOKING STATEMENTS
This press release contains statements which constitute “forward‐looking information” within the meaning of applicable securities laws, including statements regarding the plans, intentions, beliefs and current expectations of Grown Rogue and Pure Extracts (“the Companies”) with respect to future business activities. Forward‐looking information is often identified by the words “may,” “would,” “could,” “should,” “will,” “intend,” “plan,” “anticipate,” “believe,” “estimate,” “expect” or similar expressions and include information regarding: (i) statements regarding the future direction of the Companies (ii) the ability of the Company to successfully achieve its business and financial objectives, (iii) plans for expansion of the Companies into Michigan and securing applicable regulatory approvals, and (iv) expectations for other economic, business, and/or competitive factors. Investors are cautioned that forward‐looking information is not based on historical facts but instead reflect the Companies’ management’s expectations, estimates or projections concerning the business of the Companies’ future results or events based on the opinions, assumptions and estimates of management considered reasonable at the date the statements are made. Although the Companies believe that the expectations reflected in such forward‐looking information are reasonable, such information involves risks and uncertainties, and undue reliance should not be placed on such information, as unknown or unpredictable factors could have material adverse effects on future results, performance or achievements of the combined company. Among the key factors that could cause actual results to differ materially from those projected in the forward‐looking information are the following: changes in general economic, business and political conditions, including changes in the financial markets; and in particular in the ability of the Companies to raise debt and equity capital in the amounts and at the costs that it expects; adverse changes in the public perception of cannabis; decreases in the prevailing prices for cannabis and cannabis products in the markets that the Companies operate in; adverse changes in applicable laws; or adverse changes in the application or enforcement of current laws; compliance with extensive government regulation and related costs, and other risks described in the Companies’ public disclosure documents filed on www.sedar.com.
Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward‐looking information prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected. Although the Companies have attempted to identify important risks, uncertainties and factors which could cause actual results to differ materially, there may be others that cause results not to be as anticipated, estimated or intended. The Companies do not intend, and do not assume any obligation, to update this forward‐looking information except as otherwise required by applicable law.
For further information on Grown Rogue International please visit www.grownrogue.com or contact:
Obie Strickler
Chief Executive Officer
obie@grownrogue.com
Investor Relations Desk Inquiries
invest@grownrogue.com
(458) 226-2100
For further information on Pure Extracts please visit www.pureextractscorp.com/ or contact:
Pure Extracts Investor Relations
Tel: +1 604 493 2052
info@pureextractscorp.com
SAFE HARBOR STATEMENT
This press release may contain forward-looking information within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), including all statements that are not statements of historical fact regarding the intent, belief or current expectations of the Companies, its directors or its officers with respect to, among other things: (i) the Company’s financing plans; (ii) trends affecting the Companies’ financial condition or results of operations; (iii) the Companies’ growth strategy and operating strategy; and (iv) the declaration and payment of dividends. The words “may,” “would,” “will,” “expect,” “estimate,” “anticipate,” “believe,” “intend” and similar expressions and variations thereof are intended to identify forward-looking statements. Also, forward-looking statements represent our management’s beliefs and assumptions only as of the date hereof. Except as required by law, we assume no obligation to update these forward-looking statements publicly, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Companies’ ability to control, and that actual results may differ materially from those projected in the forward-looking statements as a result of various factors including the risk disclosed in Grown Rogue’s Form 20-F and 6-K filings with the Securities and Exchange Commission.
STATEMENT REGARDING UNITED STATES REGULATORY FRAMEWORK FOR CANNABIS
Pursuant to Pure Extracts’ joint venture with Golden Harvests, LLC, Pure Extracts expects to derive revenues from the cannabis industry in the State of Michigan in the United States, which industry is illegal under United States federal law. The joint venture is expected to be directly or indirectly engaged in the manufacture, possession, use, sale and distribution of cannabis in the medical and/or adult-use cannabis marketplace in the State of Michigan.
The United States federal government regulates drugs through the Controlled Substances Act (21 U.S.C. § 811) (the “CSA”), which places controlled substances, including cannabis, in a schedule. Cannabis is classified as a Schedule I drug. Under United States federal law, a Schedule I drug or substance has a high potential for abuse, no accepted medical use in the United States, and a lack of accepted safety for the use of the drug under medical supervision. The United States Food and Drug Administration has not approved cannabis as a safe and effective drug for any indication.
In the United States, cannabis is largely regulated at the state level. State laws regulating cannabis are in direct conflict with the federal Controlled Substances Act, which makes cannabis use and possession federally illegal. Although certain states authorize medical and/or adult-use cannabis production and distribution by licensed or registered entities, under United States federal law, the possession, use, cultivation, and transfer of cannabis and any cannabis-related drug paraphernalia is illegal, and any such acts are criminal acts under federal law. The Supremacy Clause of the United States Constitution establishes that the United States Constitution and federal laws made pursuant to it are paramount and in case of conflict between federal and state law, the federal law shall apply.
There is no guarantee that state laws legalizing and regulating the sale and use of cannabis will not be repealed or overturned, or that local governmental authorities will not limit the applicability of state laws within their respective jurisdictions. Unless and until the United States Congress amends the CSA with respect to medical and/or adult-use cannabis (and as to the timing or scope of any such potential amendments there can be no assurance), there is a risk that U.S. federal authorities may enforce current U.S. federal law. If the U.S. federal government begins to enforce U.S. federal laws relating to cannabis in states where the sale and use of cannabis is currently legal, or if existing applicable state laws are repealed or curtailed, Pure Extracts’ business, results of operations, financial condition and prospects would be materially adversely affected. For these reasons, Pure Extracts’ operations in the United States cannabis market (through the joint venture) may subject Pure Extracts to heightened scrutiny by regulators, stock exchanges, clearing agencies and other Canadian and U.S. authorities and is subject to a number of risks, including those risks that are described in the Companies’ public filings profile on SEDAR at www.sedar.com.
To Pure Extracts’ knowledge, no statement has been made by federal authorities or prosecutors regarding the risk of enforcement action with respect to state-sanctioned marijuana activities in the state of Michigan.
No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein.
FAQ
What is the significance of the medical Prequalification Status Letter for PRXTF?
How is cannabis sales growth affecting Pure Extracts (PRXTF)?
What are the regulatory challenges for Pure Extracts in Michigan?
What is the role of Grown Rogue in the joint venture with PRXTF?
When was the joint venture between Pure Extracts and Grown Rogue announced?
